<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03573388</url>
  </required_header>
  <id_info>
    <org_study_id>20042018</org_study_id>
    <nct_id>NCT03573388</nct_id>
  </id_info>
  <brief_title>OCT Measures Predicting FFR</brief_title>
  <acronym>OMEF</acronym>
  <official_title>OMEF: Optical-coherence-tomography (OCT) Measures Predicting Fractional-flow-reserve (FFR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <brief_summary>
    <textblock>
      Background: the decision-making process of patients with angiographically-intermediate
      coronary lesions (ICL) is clinically challenging and may benefit from adjunctive invasive
      techniques. Fractional-flow-reserve (FFR) represents the gold standard to evaluate ICL but
      optical-coherence-tomography (OCT) is a novel, promising, high resolution coronary imaging
      technique.

      Objectives:

        1. Investigate the relation between OCT and FFR parameters in ICL and understand if OCT
           measures may predict FFR.

        2. Understand if OCT parameters may predict clinical outcome of patients with ICL not
           underwent revascularization on the bases of negative FFR.

      Study design: multicentre, international, individual patient's level data pooled analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Principal investigators that enrolled stable or unstable patients with ICL who underwent both
      FFR and OCT assessment of the same lesion, will be contacted to participate the study.
      Agreeing investigators will be asked to complete a structured database by providing a series
      of key baseline clinical and angiographic data, OCT and FFR parameters.

      Collected dataset will include: sex, age, hypertension, diabetes, hypercholesterolemia,
      current smoking, family history of CAD, clinical presentation, previous PCI, previous MI,
      previous CABG, non-invasive ischemia, angina, n° of diseased vessels, diseased vessel,
      percentage diameter stenosis at quantitative coronary angiography (QCA% stenosis), length of
      stenosis at quantitative coronary angiography, presence of thrombus or ulceration, MLA, area
      stenosis at OCT, FFR protocol (intracoronary adenosine, endovenous adenosine, contrast)
      results and long term clinical follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 16, 2017</start_date>
  <completion_date type="Actual">February 18, 2018</completion_date>
  <primary_completion_date type="Actual">October 30, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>OCT measures predicting FFR - mean lumen area</measure>
    <time_frame>1 day</time_frame>
    <description>ICL mean lumen area (MLA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OCT measure predicting FFR - area stenosis</measure>
    <time_frame>1 day</time_frame>
    <description>ICL percentage area stenosis (AS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OCT measure predicting FFR - thrombus or ulceration</measure>
    <time_frame>1 day</time_frame>
    <description>Presence of thrombus or ulceration at the level of ICL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events (MACE) in untreated patients (no PCI or CABG)</measure>
    <time_frame>1 year</time_frame>
    <description>Major Adverse Cardiac Events (MACE) defined as the composite of:
cardiac death (any death not clearly attributed to non cardiac causes)
(spontaneous) myocardial infarction (MI)
surgical or percutaneous coronary revascularization of the target lesion (PCI o CABG)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">500</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>Optical coherence tomography (OCT)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical coherence tomography (OCT)</intervention_name>
    <description>Lesion OCT assessment</description>
    <arm_group_label>Optical coherence tomography (OCT)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Stable or unstable patients with intermediate coronary lesions who underwent both FFR and
        OCT assessment of the same lesion
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with angiographically-intermediate coronary lesion

          -  Patients who underwent both FFR and OCT assessment of the same lesion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Policlinico A. Gemelli. Università Cattolica del Sacro Cuore</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2018</study_first_posted>
  <last_update_submitted>June 19, 2018</last_update_submitted>
  <last_update_submitted_qc>June 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Francesco Burzotta</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Intermediate coronary lesions</keyword>
  <keyword>Fractional flow reserve</keyword>
  <keyword>Optical coherence tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

